Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Immunoassays
University of Iowa pathologists suggest best-practice advisory for SRA testing
By
Liz Carey
Utilization analysis shows confirmatory serotonin release assays may be overused.
January 7, 2025
OraSure awarded BARDA contract for Marburg virus disease test
By
LabPulse.com staff writers
OraSure Technologies was awarded federal funding for the development of a Marburg virus disease rapid antigen test.
December 2, 2024
Lucy Letby murder case flags immunoassays as unreliable for medical evidence
By
Liz Carey
At least one pathologist has said it was wrong for scientists representing Liverpool Clinical Laboratories to insist insulin poisoning was the only explanation in a series of high-profile newborn deaths in the U.K., The Telegraph reported.
October 28, 2024
WHO approves Abbott mpox test for emergency use
By
LabPulse.com staff writers
The World Health Organization (WHO) authorized Abbott Laboratories' mpox diagnostic test under its emergency use listing procedure, the first such approval by the agency in its effort to expand the diagnostic capacity of countries facing mpox outbreaks.
October 4, 2024
Seegene launches 3rd RUO mpox assay
By
LabPulse.com staff writers
After introducing two research use only (RUO) mpox assays in August, Seegene has expanded its mpox assay line with a third RUO assay designed to address the spread of the mpox virus variant clade Ib currently prevalent in the mpox outbreak in Africa.
September 10, 2024
Rapid blood test for heart attack holds promise for shorter ED stays
By
LabPulse.com staff writers
A rapid blood test that can distinguish heart attack in people presenting at emergency departments (EDs) with chest pain has been developed by researchers.
September 5, 2024
New assay developed for persistent African HIV strains
By
LabPulse.com staff writers
A multinational research team has developed a test to measure the persistence of HIV in people who have been infected by strains of the virus found predominantly in Africa, providing a necessary tool in the search for a cure for HIV.
July 9, 2024
CRISPR-based paper test could improve influenza testing access, outbreak surveillance
By
LabPulse.com staff writers
Researchers from the Broad Institute of MIT, Harvard, and Princeton University have developed a low-cost paper strip test that uses CRISPR to distinguish between the two main types of seasonal influenza, A and B, as well as subtypes H1N1 and H3N2.
June 21, 2024
FDA grants 510(k) clearance to Genetic Signature for parasitic GI infection kit
By
LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Genetic Signature's EasyScreen Gastrointestinal Parasite Detection Kit and GS1 automated molecular workflow.
June 7, 2024
Roche garners FDA EUA for 4-in-1 respiratory panel
By
LabPulse.com staff writers
Roche has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Cobas Liat SARS-CoV-2, influenza A/B, and RSV nucleic acid test.
June 10, 2024
Diasorin receives FDA 510(k) clearance for fungal infection panel
By
LabPulse.com staff writers
Diasorin has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new Liaison Plex Yeast Blood Culture assay, the second molecular multiplexing panel developed for the firm's Liaison Plex system.
June 6, 2024
University of Florida researchers develop CRISPR-based assay for HPV detection
By
LabPulse.com staff writers
Researchers at the University of Florida have developed a testing method that utilizes CRISPR gene-editing technology to detect HPV in blood or saliva samples that could promote earlier cervical cancer detection.
May 7, 2024
Page 1 of 62
Next Page
